| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | beta-adrenergic receptor activity | 2.29e-07 | 4 | 78 | 3 | GO:0004939 | |
| GeneOntologyMolecularFunction | histone deacetylase activity | 2.16e-06 | 24 | 78 | 4 | GO:0004407 | |
| GeneOntologyMolecularFunction | protein lysine deacetylase activity | 2.56e-06 | 25 | 78 | 4 | GO:0033558 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | PMS1 MRE11 MYO6 IGHMBP2 HELZ2 HLTF MACF1 NLRP1 DHX32 ATP2A1 ATP2A2 ATP2A3 | 4.37e-06 | 614 | 78 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | adrenergic receptor activity | 6.75e-06 | 10 | 78 | 3 | GO:0004935 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 9.25e-06 | 11 | 78 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 1.62e-05 | 81 | 78 | 5 | GO:0016811 | |
| GeneOntologyMolecularFunction | deacetylase activity | 1.77e-05 | 40 | 78 | 4 | GO:0019213 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 5.46e-05 | 441 | 78 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | norepinephrine binding | 8.99e-05 | 4 | 78 | 2 | GO:0051380 | |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 8.99e-05 | 4 | 78 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activator activity involved in apoptotic process | 1.95e-04 | 29 | 78 | 3 | GO:0008656 | |
| GeneOntologyMolecularFunction | peptidase activator activity involved in apoptotic process | 2.62e-04 | 32 | 78 | 3 | GO:0016505 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 2.68e-04 | 146 | 78 | 5 | GO:0016810 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 2.75e-04 | 229 | 78 | 6 | GO:0003714 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 3.73e-04 | 36 | 78 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 3.73e-04 | 36 | 78 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | helicase activity | 3.86e-04 | 158 | 78 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PMS1 IGHMBP2 HELZ2 HLTF MACF1 NLRP1 DHX32 RHOT2 ATP2A1 ATP2A2 ATP2A3 | 4.05e-04 | 840 | 78 | 11 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PMS1 IGHMBP2 HELZ2 HLTF MACF1 NLRP1 DHX32 RHOT2 ATP2A1 ATP2A2 ATP2A3 | 4.05e-04 | 840 | 78 | 11 | GO:0016818 |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 5.49e-04 | 41 | 78 | 3 | GO:0008227 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 5.62e-04 | 262 | 78 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | PMS1 IGHMBP2 HELZ2 MACF1 NLRP1 DHX32 RHOT2 ATP2A1 ATP2A2 ATP2A3 | 8.48e-04 | 775 | 78 | 10 | GO:0017111 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 9.06e-04 | 645 | 78 | 9 | GO:0140640 | |
| GeneOntologyMolecularFunction | catecholamine binding | 1.14e-03 | 13 | 78 | 2 | GO:1901338 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase regulator activity involved in apoptotic process | 1.23e-03 | 54 | 78 | 3 | GO:0043028 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PMS1 IGHMBP2 HELZ2 MACF1 NLRP1 DHX32 RHOT2 ATP2A1 ATP2A2 ATP2A3 | 1.54e-03 | 839 | 78 | 10 | GO:0016462 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.55e-03 | 127 | 78 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.84e-03 | 62 | 78 | 3 | GO:0019829 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 2.20e-03 | 66 | 78 | 3 | GO:0005080 | |
| GeneOntologyMolecularFunction | peptidase activator activity | 2.60e-03 | 70 | 78 | 3 | GO:0016504 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 3.53e-03 | 78 | 78 | 3 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 3.80e-03 | 80 | 78 | 3 | GO:0008186 | |
| GeneOntologyMolecularFunction | adrenergic receptor binding | 3.93e-03 | 24 | 78 | 2 | GO:0031690 | |
| GeneOntologyBiologicalProcess | norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure | 5.00e-08 | 3 | 77 | 3 | GO:0002025 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle fiber differentiation | 1.73e-06 | 7 | 77 | 3 | GO:1902809 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating adrenergic receptor signaling pathway | 2.14e-06 | 25 | 77 | 4 | GO:0071880 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by norepinephrine-epinephrine | 2.76e-06 | 8 | 77 | 3 | GO:0001993 | |
| GeneOntologyBiologicalProcess | brown fat cell differentiation | 5.12e-06 | 67 | 77 | 5 | GO:0050873 | |
| GeneOntologyBiologicalProcess | adrenergic receptor signaling pathway | 8.61e-06 | 35 | 77 | 4 | GO:0071875 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 9.51e-06 | 199 | 77 | 7 | GO:0051147 | |
| GeneOntologyBiologicalProcess | negative regulation of striated muscle tissue development | 1.07e-05 | 12 | 77 | 3 | GO:0045843 | |
| GeneOntologyBiologicalProcess | calcium ion transport from cytosol to endoplasmic reticulum | 1.38e-05 | 2 | 77 | 2 | GO:1903515 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle organ development | 1.77e-05 | 14 | 77 | 3 | GO:0048635 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle fiber development | 1.77e-05 | 14 | 77 | 3 | GO:0048742 | |
| GeneOntologyBiologicalProcess | skeletal muscle fiber differentiation | 2.71e-05 | 16 | 77 | 3 | GO:0098528 | |
| GeneOntologyBiologicalProcess | diet induced thermogenesis | 3.28e-05 | 17 | 77 | 3 | GO:0002024 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organism growth | 3.28e-05 | 17 | 77 | 3 | GO:0040015 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle tissue development | 3.92e-05 | 18 | 77 | 3 | GO:1901862 | |
| GeneOntologyBiologicalProcess | positive regulation of endoplasmic reticulum calcium ion concentration | 4.12e-05 | 3 | 77 | 2 | GO:0032470 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 5.98e-05 | 111 | 77 | 5 | GO:0006942 | |
| GeneOntologyBiologicalProcess | regulation of muscle tissue development | 6.10e-05 | 57 | 77 | 4 | GO:1901861 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure mediated by a chemical signal | 7.97e-05 | 61 | 77 | 4 | GO:0003044 | |
| GeneOntologyBiologicalProcess | relaxation of skeletal muscle | 8.21e-05 | 4 | 77 | 2 | GO:0090076 | |
| GeneOntologyBiologicalProcess | positive regulation of the force of heart contraction by epinephrine-norepinephrine | 8.21e-05 | 4 | 77 | 2 | GO:0001997 | |
| GeneOntologyBiologicalProcess | heat generation | 8.40e-05 | 23 | 77 | 3 | GO:0031649 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle cell differentiation | 9.74e-05 | 123 | 77 | 5 | GO:0051153 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle tissue development | 1.08e-04 | 25 | 77 | 3 | GO:0016202 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 1.09e-04 | 202 | 77 | 6 | GO:0006937 | |
| GeneOntologyBiologicalProcess | negative regulation of blood pressure | 1.37e-04 | 70 | 77 | 4 | GO:0045776 | |
| GeneOntologyBiologicalProcess | cellular response to fructose stimulus | 1.37e-04 | 5 | 77 | 2 | GO:0071332 | |
| GeneOntologyBiologicalProcess | positive regulation of the force of heart contraction by chemical signal | 1.37e-04 | 5 | 77 | 2 | GO:0003099 | |
| GeneOntologyBiologicalProcess | cytosol to endoplasmic reticulum transport | 1.37e-04 | 5 | 77 | 2 | GO:0046967 | |
| GeneOntologyBiologicalProcess | DNA repair | 1.44e-04 | 648 | 77 | 10 | GO:0006281 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle cell differentiation | 1.53e-04 | 28 | 77 | 3 | GO:2001014 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | 1.56e-04 | 530 | 77 | 9 | GO:0043434 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.61e-04 | 217 | 77 | 6 | GO:0006941 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum calcium ion homeostasis | 1.70e-04 | 29 | 77 | 3 | GO:0032469 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 1.70e-04 | 29 | 77 | 3 | GO:1903779 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 1.82e-04 | 317 | 77 | 7 | GO:0090257 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine deacetylation | 2.04e-04 | 6 | 77 | 2 | GO:0034983 | |
| GeneOntologyBiologicalProcess | regulation of muscle organ development | 2.09e-04 | 31 | 77 | 3 | GO:0048634 | |
| GeneOntologyBiologicalProcess | negative regulation of systemic arterial blood pressure | 2.30e-04 | 32 | 77 | 3 | GO:0003085 | |
| GeneOntologyBiologicalProcess | regulation of the force of heart contraction | 2.52e-04 | 33 | 77 | 3 | GO:0002026 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle cell differentiation | 2.64e-04 | 83 | 77 | 4 | GO:0051148 | |
| GeneOntologyBiologicalProcess | B cell activation | 2.83e-04 | 341 | 77 | 7 | GO:0042113 | |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure by epinephrine-norepinephrine | 2.85e-04 | 7 | 77 | 2 | GO:0003321 | |
| GeneOntologyBiologicalProcess | calcium ion import into sarcoplasmic reticulum | 2.85e-04 | 7 | 77 | 2 | GO:1990036 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle contraction | 3.00e-04 | 35 | 77 | 3 | GO:0045932 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 3.38e-04 | 249 | 77 | 6 | GO:0008016 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 3.45e-04 | 89 | 77 | 4 | GO:0055117 | |
| GeneOntologyBiologicalProcess | regulation of the force of heart contraction by chemical signal | 3.80e-04 | 8 | 77 | 2 | GO:0003057 | |
| GeneOntologyBiologicalProcess | muscle cell development | 4.16e-04 | 259 | 77 | 6 | GO:0055001 | |
| GeneOntologyBiologicalProcess | inflammatory response | HDAC9 NLRP12 PARP4 FASN NLRP9 HDAC5 HDAC4 NLRP1 PPARA NLRP4 HDAC7 PXK | 4.61e-04 | 1043 | 77 | 12 | GO:0006954 |
| GeneOntologyBiologicalProcess | relaxation of muscle | 5.17e-04 | 42 | 77 | 3 | GO:0090075 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell contraction | 5.54e-04 | 43 | 77 | 3 | GO:0086004 | |
| GeneOntologyBiologicalProcess | response to fructose | 6.07e-04 | 10 | 77 | 2 | GO:0009750 | |
| GeneOntologyBiologicalProcess | blood circulation | 6.78e-04 | 648 | 77 | 9 | GO:0008015 | |
| GeneOntologyBiologicalProcess | response to dietary excess | 7.21e-04 | 47 | 77 | 3 | GO:0002021 | |
| GeneOntologyBiologicalProcess | protein deacetylation | 7.21e-04 | 47 | 77 | 3 | GO:0006476 | |
| GeneOntologyBiologicalProcess | negative regulation of urine volume | 7.40e-04 | 11 | 77 | 2 | GO:0035811 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 7.44e-04 | 191 | 77 | 5 | GO:0007189 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 8.11e-04 | 531 | 77 | 8 | GO:0042692 | |
| GeneOntologyBiologicalProcess | positive regulation of heart contraction | 8.15e-04 | 49 | 77 | 3 | GO:0045823 | |
| GeneOntologyBiologicalProcess | skeletal muscle fiber development | 8.15e-04 | 49 | 77 | 3 | GO:0048741 | |
| GeneOntologyBiologicalProcess | DNA damage response | PMS1 HDAC9 MRE11 RIF1 PARP4 MYO6 HLTF NHEJ1 FAAP100 TOP3B TDP2 | 8.33e-04 | 959 | 77 | 11 | GO:0006974 |
| GeneOntologyBiologicalProcess | heart contraction | 8.68e-04 | 298 | 77 | 6 | GO:0060047 | |
| GeneOntologyBiologicalProcess | negative regulation of striated muscle cell differentiation | 9.16e-04 | 51 | 77 | 3 | GO:0051154 | |
| GeneOntologyBiologicalProcess | B cell differentiation | 9.36e-04 | 201 | 77 | 5 | GO:0030183 | |
| GeneOntologyBiologicalProcess | response to cold | 9.69e-04 | 52 | 77 | 3 | GO:0009409 | |
| GeneOntologyBiologicalProcess | skeletal muscle contraction | 9.69e-04 | 52 | 77 | 3 | GO:0003009 | |
| GeneOntologyBiologicalProcess | positive regulation of blood circulation | 1.02e-03 | 53 | 77 | 3 | GO:1903524 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based movement | 1.02e-03 | 53 | 77 | 3 | GO:1903115 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion import across plasma membrane | 1.04e-03 | 13 | 77 | 2 | GO:1905665 | |
| GeneOntologyBiologicalProcess | heart process | 1.05e-03 | 309 | 77 | 6 | GO:0003015 | |
| GeneOntologyBiologicalProcess | myotube cell development | 1.08e-03 | 54 | 77 | 3 | GO:0014904 | |
| GeneOntologyBiologicalProcess | regulation of myotube differentiation | 1.14e-03 | 55 | 77 | 3 | GO:0010830 | |
| GeneOntologyBiologicalProcess | intracellular transport | SNX30 TRAPPC11 ADRB2 MYO6 SUPT6H TNPO2 LMTK2 RHOT2 AP4B1 ATP2A1 ATP2A2 ATP2A3 PXK C2CD5 | 1.17e-03 | 1496 | 77 | 14 | GO:0046907 |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure | 1.20e-03 | 124 | 77 | 4 | GO:0003073 | |
| GeneOntologyBiologicalProcess | negative regulation of receptor binding | 1.22e-03 | 14 | 77 | 2 | GO:1900121 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental growth | 1.27e-03 | 126 | 77 | 4 | GO:0048640 | |
| GeneOntologyBiologicalProcess | muscle structure development | HDAC9 ADRB1 ADRB2 HDAC5 HDAC4 SUPT6H TNPO2 PPARA ATP2A2 HDAC7 | 1.29e-03 | 858 | 77 | 10 | GO:0061061 |
| GeneOntologyBiologicalProcess | protein deacylation | 1.33e-03 | 58 | 77 | 3 | GO:0035601 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 1.38e-03 | 326 | 77 | 6 | GO:1903522 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-18 production | 1.40e-03 | 15 | 77 | 2 | GO:0032661 | |
| GeneOntologyBiologicalProcess | regulation of muscle adaptation | 1.55e-03 | 133 | 77 | 4 | GO:0043502 | |
| GeneOntologyBiologicalProcess | circulatory system process | 1.60e-03 | 733 | 77 | 9 | GO:0003013 | |
| GeneOntologyBiologicalProcess | regulation of protein binding | 1.64e-03 | 228 | 77 | 5 | GO:0043393 | |
| GeneOntologyBiologicalProcess | macromolecule deacylation | 1.69e-03 | 63 | 77 | 3 | GO:0098732 | |
| GeneOntologyBiologicalProcess | response to insulin | 1.75e-03 | 342 | 77 | 6 | GO:0032868 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | HDAC9 FBN1 ADRB1 ADRB2 ADRB3 HDAC5 HDAC4 TP53INP1 TNPO2 PPARA UBASH3B HDAC7 | 1.80e-03 | 1220 | 77 | 12 | GO:0051093 |
| GeneOntologyBiologicalProcess | interleukin-18 production | 1.80e-03 | 17 | 77 | 2 | GO:0032621 | |
| GeneOntologyBiologicalProcess | regulation of blood pressure | 1.94e-03 | 237 | 77 | 5 | GO:0008217 | |
| GeneOntologyBiologicalProcess | cardiac muscle hypertrophy | 1.97e-03 | 142 | 77 | 4 | GO:0003300 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | PMS1 HDAC9 MRE11 RIF1 PARP4 SUPT6H HLTF NHEJ1 FAAP100 TOP3B TDP2 | 2.17e-03 | 1081 | 77 | 11 | GO:0006259 |
| GeneOntologyBiologicalProcess | striated muscle hypertrophy | 2.18e-03 | 146 | 77 | 4 | GO:0014897 | |
| GeneOntologyBiologicalProcess | somatic recombination of immunoglobulin gene segments | 2.20e-03 | 69 | 77 | 3 | GO:0016447 | |
| GeneOntologyBiologicalProcess | musculoskeletal movement | 2.20e-03 | 69 | 77 | 3 | GO:0050881 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion import across plasma membrane | 2.26e-03 | 19 | 77 | 2 | GO:1905664 | |
| GeneOntologyBiologicalProcess | osteoblast development | 2.26e-03 | 19 | 77 | 2 | GO:0002076 | |
| GeneOntologyBiologicalProcess | muscle hypertrophy | 2.30e-03 | 148 | 77 | 4 | GO:0014896 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 4.13e-06 | 9 | 78 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 8.07e-06 | 11 | 78 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 2.89e-04 | 85 | 78 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 3.30e-04 | 88 | 78 | 4 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 6.33e-04 | 45 | 78 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | sarcoplasm | 8.77e-04 | 114 | 78 | 4 | GO:0016528 | |
| GeneOntologyCellularComponent | endosome | ZFYVE28 SNX30 ADRB1 ADRB2 MYO6 ASAH1 OSBPL1A LMTK2 SLC26A9 AP4B1 THSD1 PXK | 1.24e-03 | 1167 | 78 | 12 | GO:0005768 |
| Domain | Histone_deAcase_II_euk | 2.81e-10 | 4 | 78 | 4 | IPR017320 | |
| Domain | Hist_deacetylase_Gln_rich_N | 7.01e-08 | 3 | 78 | 3 | IPR024643 | |
| Domain | HDAC4_Gln | 7.01e-08 | 3 | 78 | 3 | PF12203 | |
| Domain | P-type_ATPase_IIA | 7.01e-08 | 3 | 78 | 3 | IPR005782 | |
| Domain | Hist_deacetyl | 9.08e-08 | 11 | 78 | 4 | PF00850 | |
| Domain | His_deacetylse_dom | 9.08e-08 | 11 | 78 | 4 | IPR023801 | |
| Domain | - | 9.08e-08 | 11 | 78 | 4 | 3.40.800.20 | |
| Domain | His_deacetylse | 9.08e-08 | 11 | 78 | 4 | IPR000286 | |
| Domain | DAPIN | 1.94e-06 | 22 | 78 | 4 | PS50824 | |
| Domain | PYRIN | 1.94e-06 | 22 | 78 | 4 | PF02758 | |
| Domain | DAPIN | 1.94e-06 | 22 | 78 | 4 | IPR004020 | |
| Domain | PYRIN | 1.94e-06 | 22 | 78 | 4 | SM01289 | |
| Domain | NACHT | 2.35e-06 | 23 | 78 | 4 | PS50837 | |
| Domain | NACHT_NTPase | 2.35e-06 | 23 | 78 | 4 | IPR007111 | |
| Domain | Hydrolase_3 | 8.23e-06 | 10 | 78 | 3 | PF08282 | |
| Domain | ADR_fam | 8.23e-06 | 10 | 78 | 3 | IPR002233 | |
| Domain | - | 3.77e-05 | 16 | 78 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 3.77e-05 | 16 | 78 | 3 | IPR023298 | |
| Domain | ATPase_P-typ_cation-transptr_C | 4.57e-05 | 17 | 78 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 4.57e-05 | 17 | 78 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 5.47e-05 | 18 | 78 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 5.47e-05 | 18 | 78 | 3 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 6.47e-05 | 19 | 78 | 3 | IPR004014 | |
| Domain | LRR_6 | 8.17e-05 | 55 | 78 | 4 | PF13516 | |
| Domain | - | 3.19e-04 | 32 | 78 | 3 | 3.40.1110.10 | |
| Domain | - | 3.19e-04 | 32 | 78 | 3 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 4.17e-04 | 35 | 78 | 3 | IPR023299 | |
| Domain | P_typ_ATPase | 4.53e-04 | 36 | 78 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 4.53e-04 | 36 | 78 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 4.53e-04 | 36 | 78 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 4.92e-04 | 37 | 78 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 4.92e-04 | 37 | 78 | 3 | PF00122 | |
| Domain | - | 6.20e-04 | 93 | 78 | 4 | 1.10.533.10 | |
| Domain | DEATH-like_dom | 7.85e-04 | 99 | 78 | 4 | IPR011029 | |
| Domain | P-loop_NTPase | NLRP12 NLRP9 MYO6 IGHMBP2 HELZ2 HLTF NLRP1 DHX32 RHOT2 NLRP4 | 2.71e-03 | 848 | 78 | 10 | IPR027417 |
| Domain | ARM-type_fold | 2.93e-03 | 339 | 78 | 6 | IPR016024 | |
| Domain | - | 3.83e-03 | 746 | 78 | 9 | 3.40.50.300 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA | 3.65e-06 | 8 | 58 | 3 | M47955 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 4.91e-06 | 28 | 58 | 4 | M6177 | |
| Pathway | REACTOME_ADRENOCEPTORS | 5.46e-06 | 9 | 58 | 3 | M27302 | |
| Pathway | REACTOME_ADRENOCEPTORS | 5.46e-06 | 9 | 58 | 3 | MM15009 | |
| Pathway | WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS | 7.47e-06 | 31 | 58 | 4 | M39714 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 7.95e-06 | 178 | 58 | 7 | M2890 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 8.51e-06 | 32 | 58 | 4 | M39521 | |
| Pathway | PID_HDAC_CLASSII_PATHWAY | 1.09e-05 | 34 | 58 | 4 | M30 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.42e-05 | 12 | 58 | 3 | M27326 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.33e-05 | 14 | 58 | 3 | MM15052 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 3.01e-05 | 147 | 58 | 6 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 3.50e-05 | 151 | 58 | 6 | M39329 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 3.56e-05 | 16 | 58 | 3 | M39849 | |
| Pathway | WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE | 4.03e-05 | 47 | 58 | 4 | M39518 | |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 4.03e-05 | 47 | 58 | 4 | MM15296 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.39e-05 | 48 | 58 | 4 | M611 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 5.16e-05 | 18 | 58 | 3 | M614 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 6.37e-05 | 246 | 58 | 7 | M10189 | |
| Pathway | WP_CARDIAC_HYPERTROPHIC_RESPONSE | 7.52e-05 | 55 | 58 | 4 | M39685 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 9.27e-05 | 58 | 58 | 4 | M29616 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.10e-04 | 23 | 58 | 3 | MM14954 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 1.54e-04 | 66 | 58 | 4 | M101 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 1.61e-04 | 26 | 58 | 3 | M2499 | |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 1.73e-04 | 68 | 58 | 4 | M27587 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.80e-04 | 27 | 58 | 3 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 2.01e-04 | 28 | 58 | 3 | M924 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.40e-04 | 74 | 58 | 4 | M616 | |
| Pathway | WP_MONOAMINE_GPCRS | 2.74e-04 | 31 | 58 | 3 | MM15871 | |
| Pathway | WP_MONOAMINE_GPCRS | 3.30e-04 | 33 | 58 | 3 | M39585 | |
| Pathway | WP_NONHOMOLOGOUS_END_JOINING | 3.45e-04 | 7 | 58 | 2 | MM15989 | |
| Pathway | WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY | 6.31e-04 | 41 | 58 | 3 | M39698 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 6.72e-04 | 97 | 58 | 4 | MM15926 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 6.77e-04 | 42 | 58 | 3 | M5868 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 6.77e-04 | 42 | 58 | 3 | M27172 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 6.77e-04 | 42 | 58 | 3 | MM14971 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 7.26e-04 | 99 | 58 | 4 | MM15905 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 7.83e-04 | 101 | 58 | 4 | M39448 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 8.74e-04 | 104 | 58 | 4 | M39625 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 8.93e-04 | 11 | 58 | 2 | M22027 | |
| Pathway | KEGG_NON_HOMOLOGOUS_END_JOINING | 1.26e-03 | 13 | 58 | 2 | M7857 | |
| Pathway | REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN | 1.26e-03 | 13 | 58 | 2 | M27240 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NON_HOMOLOGOUS_END_JOINING | 1.26e-03 | 13 | 58 | 2 | M47837 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.41e-03 | 54 | 58 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.41e-03 | 54 | 58 | 3 | MM15202 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 1.47e-03 | 14 | 58 | 2 | MM1473 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 1.49e-03 | 55 | 58 | 3 | M27001 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.49e-03 | 55 | 58 | 3 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.65e-03 | 57 | 58 | 3 | MM15643 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 1.69e-03 | 15 | 58 | 2 | M47794 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 1.69e-03 | 15 | 58 | 2 | M15181 | |
| Pathway | REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES | 1.92e-03 | 16 | 58 | 2 | M27045 | |
| Pathway | WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS | 2.44e-03 | 18 | 58 | 2 | M39679 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 2.44e-03 | 18 | 58 | 2 | MM1549 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 2.44e-03 | 18 | 58 | 2 | MM15034 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.44e-03 | 18 | 58 | 2 | M26942 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 3.04e-03 | 146 | 58 | 4 | MM15292 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 3.48e-03 | 74 | 58 | 3 | MM15962 | |
| Pathway | WP_FATTY_ACID_BIOSYNTHESIS | 3.65e-03 | 22 | 58 | 2 | M39440 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 3.68e-03 | 154 | 58 | 4 | M27832 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 3.76e-03 | 76 | 58 | 3 | MM15051 | |
| Pathway | WP_ESTROGEN_SIGNALING | 3.90e-03 | 77 | 58 | 3 | MM15934 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 3.94e-03 | 157 | 58 | 4 | M4904 | |
| Pathway | WP_FATTY_ACID_BIOSYNTHESIS | 3.98e-03 | 23 | 58 | 2 | MM15885 | |
| Pubmed | Class IIa histone deacetylases: conducting development and differentiation. | 2.47e-11 | 4 | 79 | 4 | 19412888 | |
| Pubmed | 1.23e-10 | 5 | 79 | 4 | 15194749 | ||
| Pubmed | Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. | 1.71e-09 | 8 | 79 | 4 | 17786239 | |
| Pubmed | Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. | 3.08e-09 | 9 | 79 | 4 | 11466315 | |
| Pubmed | 3.08e-09 | 9 | 79 | 4 | 15367668 | ||
| Pubmed | 3.08e-09 | 9 | 79 | 4 | 16260608 | ||
| Pubmed | 5.12e-09 | 10 | 79 | 4 | 12711221 | ||
| Pubmed | 5.12e-09 | 10 | 79 | 4 | 28028172 | ||
| Pubmed | 8.04e-09 | 11 | 79 | 4 | 31223056 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 15079793 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 18801900 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 28752049 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 24885710 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 15932670 | ||
| Pubmed | Trp64Arg polymorphism in ADRB3 gene is associated with elite endurance performance. | 1.13e-08 | 3 | 79 | 3 | 19553224 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 34483955 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 15479221 | ||
| Pubmed | betaAR signaling required for diet-induced thermogenesis and obesity resistance. | 1.13e-08 | 3 | 79 | 3 | 12161655 | |
| Pubmed | Role of β-adrenoceptors in glucose uptake in astrocytes using β-adrenoceptor knockout mice. | 1.13e-08 | 3 | 79 | 3 | 21138422 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 26566631 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 23473322 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 18239290 | ||
| Pubmed | Norepinephrine induces lipolysis in beta1/beta2/beta3-adrenoceptor knockout mice. | 1.13e-08 | 3 | 79 | 3 | 15939797 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 15464701 | ||
| Pubmed | Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. | 1.13e-08 | 3 | 79 | 3 | 11509672 | |
| Pubmed | Control of 4E-BP1 expression in mouse brown adipose tissue by the beta3-adrenoceptor. | 1.13e-08 | 3 | 79 | 3 | 15474034 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 19420258 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 17345787 | ||
| Pubmed | [Association of beta-adrenoceptor gene polymorphism with resting heart rate]. | 1.13e-08 | 3 | 79 | 3 | 17591269 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 16767221 | ||
| Pubmed | A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. | 1.13e-08 | 3 | 79 | 3 | 11854867 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 15833937 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 16410239 | ||
| Pubmed | Expression and functional role of beta-adrenoceptors in the human urinary bladder urothelium. | 1.13e-08 | 3 | 79 | 3 | 18311486 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 23297420 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 11737201 | ||
| Pubmed | Expression of β-adrenergic receptor subtypes in human normal and dilated ureter. | 1.13e-08 | 3 | 79 | 3 | 28756611 | |
| Pubmed | Association of beta-adrenoceptor single nucleotide polymorphisms with resting heart rate. | 1.13e-08 | 3 | 79 | 3 | 17270896 | |
| Pubmed | Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors. | 1.13e-08 | 3 | 79 | 3 | 10358009 | |
| Pubmed | Diverse evolutionary histories for beta-adrenoreceptor genes in humans. | 1.13e-08 | 3 | 79 | 3 | 19576569 | |
| Pubmed | Expression of beta adrenergic receptors in mouse oocytes and preimplantation embryos. | 1.13e-08 | 3 | 79 | 3 | 15791602 | |
| Pubmed | Total beta-adrenoceptor deficiency results in cardiac hypotrophy and negative inotropy. | 1.13e-08 | 3 | 79 | 3 | 20406048 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 12387862 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 7738011 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 21366703 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 23133676 | ||
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 15917856 | ||
| Pubmed | Kinase signalling in excitatory neurons regulates sleep quantity and depth. | 1.20e-08 | 12 | 79 | 4 | 36477539 | |
| Pubmed | Histone deacetylase expression patterns in developing murine optic nerve. | 2.43e-08 | 14 | 79 | 4 | 25011550 | |
| Pubmed | 2.43e-08 | 14 | 79 | 4 | 15601857 | ||
| Pubmed | 2.43e-08 | 14 | 79 | 4 | 20403135 | ||
| Pubmed | 2.43e-08 | 14 | 79 | 4 | 12563287 | ||
| Pubmed | 2.43e-08 | 14 | 79 | 4 | 21953612 | ||
| Pubmed | Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. | 2.43e-08 | 14 | 79 | 4 | 15537544 | |
| Pubmed | Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. | 4.39e-08 | 16 | 79 | 4 | 16873063 | |
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 29715048 | ||
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 27206969 | ||
| Pubmed | Somatic Mutation of NLRP Genes in Gastric and Colonic Cancers. | 4.50e-08 | 4 | 79 | 3 | 34257569 | |
| Pubmed | The nongastric H+-K+-ATPases: molecular and functional properties. | 4.50e-08 | 4 | 79 | 3 | 10362770 | |
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 17446185 | ||
| Pubmed | Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. | 4.50e-08 | 4 | 79 | 3 | 17512307 | |
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 18331634 | ||
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 20144152 | ||
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 21976502 | ||
| Pubmed | Adrenoceptor-related decrease in serum triglycerides is independent of PPARα activation. | 4.50e-08 | 4 | 79 | 3 | 31230416 | |
| Pubmed | Vagal tone dominates autonomic control of mouse heart rate at thermoneutrality. | 4.50e-08 | 4 | 79 | 3 | 18245567 | |
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 20203292 | ||
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 25110346 | ||
| Pubmed | Physiological consequences of beta-adrenergic receptor disruption. | 4.50e-08 | 4 | 79 | 3 | 9826121 | |
| Pubmed | mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. | 4.50e-08 | 4 | 79 | 3 | 10748098 | |
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 18625943 | ||
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 9305915 | ||
| Pubmed | 4.50e-08 | 4 | 79 | 3 | 29123236 | ||
| Pubmed | 7.36e-08 | 18 | 79 | 4 | 18824292 | ||
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 28724789 | ||
| Pubmed | A novel corepressor, BCoR-L1, represses transcription through an interaction with CtBP. | 1.12e-07 | 5 | 79 | 3 | 17379597 | |
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 20831043 | ||
| Pubmed | The central melanocortin system directly controls peripheral lipid metabolism. | 1.12e-07 | 5 | 79 | 3 | 17885689 | |
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 20188095 | ||
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 26132918 | ||
| Pubmed | GDF15 promotes weight loss by enhancing energy expenditure in muscle. | 1.12e-07 | 5 | 79 | 3 | 37380764 | |
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 29589323 | ||
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 16876797 | ||
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 29514069 | ||
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 19893013 | ||
| Pubmed | 1.12e-07 | 5 | 79 | 3 | 18332106 | ||
| Pubmed | 1.75e-07 | 22 | 79 | 4 | 28890335 | ||
| Pubmed | 2.22e-07 | 58 | 79 | 5 | 21884692 | ||
| Pubmed | A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. | 2.24e-07 | 6 | 79 | 3 | 11279209 | |
| Pubmed | 2.24e-07 | 6 | 79 | 3 | 18339811 | ||
| Pubmed | Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor. | 2.24e-07 | 6 | 79 | 3 | 11929873 | |
| Pubmed | Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. | 2.24e-07 | 6 | 79 | 3 | 16356933 | |
| Pubmed | Association between polymorphisms in candidate genes and morbid obesity. | 2.24e-07 | 6 | 79 | 3 | 11466580 | |
| Pubmed | Leptin engages a hypothalamic neurocircuitry to permit survival in the absence of insulin. | 2.24e-07 | 6 | 79 | 3 | 24011077 | |
| Pubmed | 2.24e-07 | 6 | 79 | 3 | 16980613 | ||
| Pubmed | 2.24e-07 | 6 | 79 | 3 | 19351956 | ||
| Pubmed | 2.24e-07 | 6 | 79 | 3 | 20044737 | ||
| Pubmed | 2.24e-07 | 6 | 79 | 3 | 35076395 | ||
| Pubmed | MRE11 RIF1 FASN PELP1 SUPT6H RRP9 HELZ2 ELP1 MACF1 ATP2A2 VIRMA | 2.67e-07 | 653 | 79 | 11 | 22586326 | |
| Pubmed | A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response. | 3.01e-07 | 25 | 79 | 4 | 12544508 | |
| Interaction | AHRR interactions | 1.86e-06 | 7 | 77 | 3 | int:AHRR | |
| Interaction | CYREN interactions | 2.76e-06 | 26 | 77 | 4 | int:CYREN | |
| Interaction | FHIP1A interactions | 7.41e-06 | 33 | 77 | 4 | int:FHIP1A | |
| Interaction | BTBD7 interactions | 8.66e-06 | 11 | 77 | 3 | int:BTBD7 | |
| Interaction | ZCCHC14 interactions | 1.18e-05 | 37 | 77 | 4 | int:ZCCHC14 | |
| Interaction | SLC52A2 interactions | 1.49e-05 | 13 | 77 | 3 | int:SLC52A2 | |
| Interaction | ZNF236 interactions | 1.89e-05 | 14 | 77 | 3 | int:ZNF236 | |
| Interaction | FRY interactions | 2.90e-05 | 16 | 77 | 3 | int:FRY | |
| Interaction | RAB43 interactions | 3.10e-05 | 47 | 77 | 4 | int:RAB43 | |
| Interaction | PIEZO1 interactions | 3.10e-05 | 47 | 77 | 4 | int:PIEZO1 | |
| Interaction | TOP3B interactions | SNX30 FASN HDAC4 PELP1 MYO6 MEX3D HELZ2 LMTK2 RHOT2 PPARA FAAP100 ATP2A3 SH2B2 HDAC7 TOP3B MEX3B ADCY9 | 3.14e-05 | 1470 | 77 | 17 | int:TOP3B |
| Interaction | BCL2 interactions | 3.77e-05 | 163 | 77 | 6 | int:BCL2 | |
| Interaction | NRIP1 interactions | 4.77e-05 | 170 | 77 | 6 | int:NRIP1 | |
| Interaction | MEF2C interactions | 5.39e-05 | 54 | 77 | 4 | int:MEF2C | |
| Interaction | REV3L interactions | 6.22e-05 | 56 | 77 | 4 | int:REV3L | |
| Interaction | NCOR2 interactions | 6.73e-05 | 264 | 77 | 7 | int:NCOR2 | |
| Interaction | DTX4 interactions | 7.84e-05 | 22 | 77 | 3 | int:DTX4 | |
| Interaction | MFSD2A interactions | 8.60e-05 | 4 | 77 | 2 | int:MFSD2A | |
| Interaction | SLC2A4RG interactions | 8.60e-05 | 4 | 77 | 2 | int:SLC2A4RG | |
| Interaction | DISP2 interactions | 8.60e-05 | 4 | 77 | 2 | int:DISP2 | |
| Interaction | HSD17B4 interactions | 8.83e-05 | 190 | 77 | 6 | int:HSD17B4 | |
| Interaction | CDC5L interactions | PMS1 MRE11 NSUN5 RIF1 PARP4 FASN HDAC5 HDAC4 HLTF ELP1 MACF1 VIRMA | 9.13e-05 | 855 | 77 | 12 | int:CDC5L |
| Interaction | MCF2L interactions | 1.02e-04 | 24 | 77 | 3 | int:MCF2L | |
| Interaction | INPP4A interactions | 1.02e-04 | 24 | 77 | 3 | int:INPP4A | |
| Interaction | ZFX interactions | 1.02e-04 | 24 | 77 | 3 | int:ZFX | |
| Interaction | SIRT7 interactions | MRE11 RIF1 FASN PELP1 SUPT6H RRP9 HELZ2 ELP1 MACF1 ATP2A2 VIRMA | 1.17e-04 | 744 | 77 | 11 | int:SIRT7 |
| Interaction | HELZ2 interactions | 1.26e-04 | 67 | 77 | 4 | int:HELZ2 | |
| Interaction | BAHD1 interactions | 1.26e-04 | 67 | 77 | 4 | int:BAHD1 | |
| Interaction | TPTE interactions | 1.36e-04 | 129 | 77 | 5 | int:TPTE | |
| Interaction | CLMN interactions | 1.41e-04 | 69 | 77 | 4 | int:CLMN | |
| Interaction | SNX30 interactions | 1.47e-04 | 27 | 77 | 3 | int:SNX30 | |
| Interaction | GPR45 interactions | 1.49e-04 | 300 | 77 | 7 | int:GPR45 | |
| Interaction | ITPR3 interactions | 1.57e-04 | 211 | 77 | 6 | int:ITPR3 | |
| Interaction | ULK4 interactions | 1.64e-04 | 28 | 77 | 3 | int:ULK4 | |
| Interaction | TRIM56 interactions | 1.80e-04 | 137 | 77 | 5 | int:TRIM56 | |
| Interaction | TNRC6C interactions | 1.86e-04 | 138 | 77 | 5 | int:TNRC6C | |
| Interaction | FAM162A interactions | 2.05e-04 | 76 | 77 | 4 | int:FAM162A | |
| Interaction | MEF2A interactions | 2.05e-04 | 76 | 77 | 4 | int:MEF2A | |
| Interaction | ADRB3 interactions | 2.14e-04 | 6 | 77 | 2 | int:ADRB3 | |
| Interaction | FZD7 interactions | 2.16e-04 | 77 | 77 | 4 | int:FZD7 | |
| Interaction | UBN1 interactions | 2.16e-04 | 77 | 77 | 4 | int:UBN1 | |
| Interaction | ZBED4 interactions | 2.23e-04 | 31 | 77 | 3 | int:ZBED4 | |
| Interaction | PLXND1 interactions | 2.23e-04 | 31 | 77 | 3 | int:PLXND1 | |
| Interaction | IRS1 interactions | 2.34e-04 | 145 | 77 | 5 | int:IRS1 | |
| Interaction | BCL6 interactions | 2.44e-04 | 229 | 77 | 6 | int:BCL6 | |
| Interaction | AP4S1 interactions | 2.46e-04 | 32 | 77 | 3 | int:AP4S1 | |
| Interaction | GRIK2 interactions | 2.46e-04 | 32 | 77 | 3 | int:GRIK2 | |
| Interaction | TMEM143 interactions | 2.46e-04 | 32 | 77 | 3 | int:TMEM143 | |
| Interaction | CLASP2 interactions | 2.50e-04 | 147 | 77 | 5 | int:CLASP2 | |
| Interaction | LRRC8B interactions | 2.69e-04 | 33 | 77 | 3 | int:LRRC8B | |
| Interaction | LINC00839 interactions | 2.88e-04 | 83 | 77 | 4 | int:LINC00839 | |
| Interaction | ANKRA2 interactions | 2.95e-04 | 34 | 77 | 3 | int:ANKRA2 | |
| Interaction | AKNA interactions | 2.99e-04 | 7 | 77 | 2 | int:AKNA | |
| Interaction | BCORL1 interactions | 3.15e-04 | 85 | 77 | 4 | int:BCORL1 | |
| Interaction | IKZF4 interactions | 3.50e-04 | 36 | 77 | 3 | int:IKZF4 | |
| Interaction | ANKRD11 interactions | 3.59e-04 | 159 | 77 | 5 | int:ANKRD11 | |
| Interaction | PRR12 interactions | 3.60e-04 | 88 | 77 | 4 | int:PRR12 | |
| Interaction | TRIB3 interactions | 3.69e-04 | 160 | 77 | 5 | int:TRIB3 | |
| GeneFamily | Histone deacetylases, class IIA | 8.88e-11 | 4 | 57 | 4 | 992 | |
| GeneFamily | NLR family | 1.07e-06 | 25 | 57 | 4 | 666 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 1.07e-06 | 25 | 57 | 4 | 994 | |
| GeneFamily | ATPases Ca2+ transporting | 2.46e-06 | 9 | 57 | 3 | 1209 | |
| GeneFamily | Adrenoceptors | 2.46e-06 | 9 | 57 | 3 | 169 | |
| GeneFamily | UPF1 like RNA helicases | 5.27e-04 | 11 | 57 | 2 | 1169 | |
| GeneFamily | Ring finger proteins | 1.10e-02 | 275 | 57 | 4 | 58 | |
| Coexpression | NRL_DN.V1_DN | 2.99e-06 | 132 | 79 | 6 | M2797 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-06 | 194 | 79 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | COVID-19_Mild-Neu_2|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 1.38e-05 | 172 | 79 | 5 | f5fd08b42c002d4693646b27e7b708eceb49524f | |
| ToppCell | P28-Hematopoietic-Erythroid|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.46e-05 | 83 | 79 | 4 | e548e5c7b16c895b360a00f3d6fc1a7eb3d19294 | |
| ToppCell | P28-Hematopoietic-Erythroid-enucleate_erythrocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.46e-05 | 83 | 79 | 4 | c7ff56d4c7582fc497057cf3d5497fbd13c183cc | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 187 | 79 | 5 | 3ca3954f45f167e98a230f2847f0582d74fcd32e | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 2.12e-05 | 188 | 79 | 5 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.23e-05 | 190 | 79 | 5 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.29e-05 | 191 | 79 | 5 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-05 | 193 | 79 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-05 | 193 | 79 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.52e-05 | 195 | 79 | 5 | d9694db6bf239636d1335016878c98f6ee2eb0eb | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 195 | 79 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 195 | 79 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-05 | 199 | 79 | 5 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| Drug | arbutamine | 4.02e-08 | 3 | 79 | 3 | ctd:C076559 | |
| Drug | N-(3-hydroxy-1-(naphthalen-1-yl)-1,8,11-trioxa-5-azatridecan-13-yl)-6-(2-(2-(4,4-difluoro-4,4a-dihydro-5-(thiophen-2-yl)-4-bora-3a,4a-diaza-s-indacene-3-yl)vinyl)phenoxyacetamido)hexanamide | 4.02e-08 | 3 | 79 | 3 | ctd:C568515 | |
| Drug | 3-iodopindolol | 4.02e-08 | 3 | 79 | 3 | CID000123825 | |
| Drug | p-azidobenzylcarazolol | 4.02e-08 | 3 | 79 | 3 | CID000133262 | |
| Drug | Fenoterol | 4.02e-08 | 3 | 79 | 3 | DB01288 | |
| Drug | LCB 2183 | 4.02e-08 | 3 | 79 | 3 | CID000133046 | |
| Drug | U-43,465F | 4.02e-08 | 3 | 79 | 3 | CID000134388 | |
| Drug | Arbutamine | 4.02e-08 | 3 | 79 | 3 | DB01102 | |
| Drug | broxaterol | 4.02e-08 | 3 | 79 | 3 | ctd:C045916 | |
| Drug | pBABC | 4.02e-08 | 3 | 79 | 3 | CID000126676 | |
| Drug | EXP063 | 4.02e-08 | 3 | 79 | 3 | CID003037493 | |
| Drug | ICYP-azide-2 | 4.02e-08 | 3 | 79 | 3 | CID003036190 | |
| Drug | BAM-CYP | 4.02e-08 | 3 | 79 | 3 | CID000125252 | |
| Drug | butofilolol | 4.02e-08 | 3 | 79 | 3 | CID000068838 | |
| Drug | soquinolol | 4.02e-08 | 3 | 79 | 3 | CID000068811 | |
| Drug | CS 476 | 4.02e-08 | 3 | 79 | 3 | CID000100459 | |
| Drug | exaprolol | 4.02e-08 | 3 | 79 | 3 | CID000065484 | |
| Drug | AHR-9377 | 4.02e-08 | 3 | 79 | 3 | CID000054961 | |
| Drug | dicyclopropyl ketoxime | 4.02e-08 | 3 | 79 | 3 | CID000015072 | |
| Drug | Oberadilol | 4.02e-08 | 3 | 79 | 3 | CID003047798 | |
| Drug | CGP-12177-NBD | 4.02e-08 | 3 | 79 | 3 | CID003081105 | |
| Drug | Bupranolol | 4.02e-08 | 3 | 79 | 3 | DB08808 | |
| Drug | p-azidoclonidine | 4.02e-08 | 3 | 79 | 3 | CID003035819 | |
| Drug | ICYP-azide-1 | 4.02e-08 | 3 | 79 | 3 | CID000133837 | |
| Drug | AC1L4W2Z | 4.02e-08 | 3 | 79 | 3 | CID000193350 | |
| Drug | H 216/44 | 4.02e-08 | 3 | 79 | 3 | CID000130141 | |
| Drug | AC1L1TT8 | 4.02e-08 | 3 | 79 | 3 | CID000060729 | |
| Drug | ADATN | 4.02e-08 | 3 | 79 | 3 | CID000133861 | |
| Drug | bopindolol | 9.37e-08 | 13 | 79 | 4 | CID000044112 | |
| Drug | v315 | 1.60e-07 | 4 | 79 | 3 | CID000053925 | |
| Drug | NHNPNBE | 1.60e-07 | 4 | 79 | 3 | CID006453817 | |
| Drug | eclanamine | 1.60e-07 | 4 | 79 | 3 | CID000051228 | |
| Drug | Tobanum | 1.60e-07 | 4 | 79 | 3 | CID000065814 | |
| Drug | flestolol | 1.60e-07 | 4 | 79 | 3 | CID000055884 | |
| Drug | DAPN | 1.60e-07 | 4 | 79 | 3 | CID000125184 | |
| Drug | SOM-1122 | 1.60e-07 | 4 | 79 | 3 | CID000068918 | |
| Drug | tienoxolol | 1.60e-07 | 4 | 79 | 3 | CID000065678 | |
| Drug | Alp-NBD | 1.60e-07 | 4 | 79 | 3 | CID000126953 | |
| Drug | i 583 | 1.60e-07 | 4 | 79 | 3 | CID000072881 | |
| Drug | cyanopindolol | 1.60e-07 | 4 | 79 | 3 | ctd:C047975 | |
| Drug | acebutolol azide | 1.60e-07 | 4 | 79 | 3 | CID000133410 | |
| Drug | CGP 20712A | 1.60e-07 | 4 | 79 | 3 | ctd:C049763 | |
| Drug | iodoazidobenzylpindolol | 1.60e-07 | 4 | 79 | 3 | CID000132676 | |
| Drug | i-Pr | 2.04e-07 | 73 | 79 | 6 | CID000448400 | |
| Drug | U754 | 3.09e-07 | 17 | 79 | 4 | CID000062824 | |
| Drug | synephrine | 3.96e-07 | 18 | 79 | 4 | CID000007172 | |
| Drug | HHCA | 4.00e-07 | 5 | 79 | 3 | CID009576894 | |
| Drug | Propranolol | 4.00e-07 | 5 | 79 | 3 | DB00571 | |
| Drug | oxyfedrine | 4.00e-07 | 5 | 79 | 3 | CID000027454 | |
| Drug | ms-27 | 4.00e-07 | 5 | 79 | 3 | CID016122504 | |
| Drug | Clenbuterol | 4.00e-07 | 5 | 79 | 3 | DB01407 | |
| Drug | AC1Q7AC1 | 4.00e-07 | 5 | 79 | 3 | CID000122310 | |
| Drug | fluorocarazolol | 4.00e-07 | 5 | 79 | 3 | CID000133038 | |
| Drug | S 9871 | 4.00e-07 | 5 | 79 | 3 | CID003036124 | |
| Drug | 6-Hdpei | 4.00e-07 | 5 | 79 | 3 | CID000137395 | |
| Drug | DJ-7141 | 4.00e-07 | 5 | 79 | 3 | CID000174123 | |
| Drug | 2,6-DMC | 4.00e-07 | 5 | 79 | 3 | CID000078576 | |
| Drug | NF503 | 4.00e-07 | 5 | 79 | 3 | CID005311251 | |
| Drug | MPV-2426 | 4.00e-07 | 5 | 79 | 3 | CID006433097 | |
| Drug | Bopindolol | 4.00e-07 | 5 | 79 | 3 | DB08807 | |
| Drug | NA--can | 4.00e-07 | 5 | 79 | 3 | CID000007387 | |
| Drug | sibenadet | 4.00e-07 | 5 | 79 | 3 | CID000183811 | |
| Drug | pafenolol | 4.00e-07 | 5 | 79 | 3 | CID000071144 | |
| Drug | lidamidine | 4.00e-07 | 5 | 79 | 3 | CID000047509 | |
| Drug | NSC3852 | 6.23e-07 | 20 | 79 | 4 | CID000019103 | |
| Drug | LY 171555 | 6.31e-07 | 142 | 79 | 7 | CID000001257 | |
| Drug | 6-fluoronorepinephrine | 7.68e-07 | 21 | 79 | 4 | CID000001862 | |
| Drug | reproterol | 7.68e-07 | 21 | 79 | 4 | CID000025654 | |
| Drug | bevantolol | 7.98e-07 | 6 | 79 | 3 | CID000002372 | |
| Drug | Br-pindolol | 7.98e-07 | 6 | 79 | 3 | CID000125847 | |
| Drug | HUK 978 | 7.98e-07 | 6 | 79 | 3 | CID000065826 | |
| Drug | 2-fluoronorepinephrine | 7.98e-07 | 6 | 79 | 3 | CID000172745 | |
| Drug | 4-hydroxyclonidine | 7.98e-07 | 6 | 79 | 3 | CID000092660 | |
| Drug | 1-(benzofuran-7-yl)piperazine | 7.98e-07 | 6 | 79 | 3 | CID010465458 | |
| Drug | indenolol | 7.98e-07 | 6 | 79 | 3 | CID000071955 | |
| Drug | TA-2005 | 7.98e-07 | 6 | 79 | 3 | CID000063951 | |
| Drug | adaprolol | 7.98e-07 | 6 | 79 | 3 | CID000060732 | |
| Drug | broxaterol | 7.98e-07 | 6 | 79 | 3 | CID000071149 | |
| Drug | milrinone | 9.12e-07 | 150 | 79 | 7 | CID000004197 | |
| Drug | DCCD | 9.54e-07 | 151 | 79 | 7 | CID000010868 | |
| Drug | lanthanum chloride hydrate | 1.13e-06 | 23 | 79 | 4 | CID000165791 | |
| Drug | trimetoquinol | 1.35e-06 | 24 | 79 | 4 | CID000005581 | |
| Drug | medroxalol | 1.39e-06 | 7 | 79 | 3 | CID000041835 | |
| Drug | metipranolol | 1.39e-06 | 7 | 79 | 3 | CID000031477 | |
| Drug | bornaprolol | 1.39e-06 | 7 | 79 | 3 | CID000068863 | |
| Drug | amidephrine | 1.39e-06 | 7 | 79 | 3 | CID000015009 | |
| Drug | tazolol | 1.39e-06 | 7 | 79 | 3 | CID000071720 | |
| Drug | Oxprenolol | 1.39e-06 | 7 | 79 | 3 | ctd:D010096 | |
| Drug | Isoproterenol | 1.39e-06 | 7 | 79 | 3 | DB01064 | |
| Drug | arbutamine | 1.39e-06 | 7 | 79 | 3 | CID000060789 | |
| Drug | D-triiodothyronine | FASN ADRB1 ADRB2 ADRB3 MYO6 PPARA ATP2A1 ATP2A2 ATP2A3 SLC2A5 | 1.50e-06 | 409 | 79 | 10 | CID000000861 |
| Drug | AC1L1G3W | 1.69e-06 | 237 | 79 | 8 | CID000003514 | |
| Drug | metaproterenol | 1.89e-06 | 26 | 79 | 4 | CID000004086 | |
| Drug | theophylline | 1.92e-06 | 241 | 79 | 8 | CID000002153 | |
| Drug | hexoprenaline | 2.22e-06 | 8 | 79 | 3 | CID000003609 | |
| Drug | soterenol | 2.22e-06 | 8 | 79 | 3 | CID000026162 | |
| Drug | pirbuterol | 2.22e-06 | 8 | 79 | 3 | CID000004845 | |
| Drug | HOKU-81 | 2.22e-06 | 8 | 79 | 3 | CID000162846 | |
| Drug | acrinor | 2.22e-06 | 8 | 79 | 3 | CID005489637 | |
| Drug | rimiterol | 2.22e-06 | 8 | 79 | 3 | CID000036283 | |
| Disease | Brody myopathy (implicated_via_orthology) | 1.78e-08 | 3 | 78 | 3 | DOID:0050692 (implicated_via_orthology) | |
| Disease | heart disease (implicated_via_orthology) | 3.11e-06 | 38 | 78 | 4 | DOID:114 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | MRE11 RIF1 FASN NLRP9 HDAC4 KCNT2 RRP9 ELP1 MACF1 DHX32 ATP2A3 HDAC7 SLC2A5 | 4.50e-06 | 1074 | 78 | 13 | C0006142 |
| Disease | Congestive heart failure | 1.12e-05 | 110 | 78 | 5 | C0018802 | |
| Disease | Heart failure | 1.12e-05 | 110 | 78 | 5 | C0018801 | |
| Disease | Left-Sided Heart Failure | 1.12e-05 | 110 | 78 | 5 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 1.12e-05 | 110 | 78 | 5 | C0235527 | |
| Disease | Heart Decompensation | 1.12e-05 | 110 | 78 | 5 | C1961112 | |
| Disease | Myocardial Failure | 1.12e-05 | 110 | 78 | 5 | C1959583 | |
| Disease | Lipidemias | 1.18e-05 | 17 | 78 | 3 | C1706412 | |
| Disease | Hyperlipidemia | 1.18e-05 | 17 | 78 | 3 | C0020473 | |
| Disease | periodontitis (implicated_via_orthology) | 2.07e-05 | 3 | 78 | 2 | DOID:824 (implicated_via_orthology) | |
| Disease | cystic fibrosis (is_marker_for) | 2.24e-05 | 62 | 78 | 4 | DOID:1485 (is_marker_for) | |
| Disease | scoliosis (is_implicated_in) | 4.12e-05 | 4 | 78 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | abdominal obesity-metabolic syndrome 1 (implicated_via_orthology) | 6.86e-05 | 5 | 78 | 2 | DOID:14221 (implicated_via_orthology) | |
| Disease | blood pressure, chronic obstructive pulmonary disease | 8.34e-05 | 32 | 78 | 3 | EFO_0000341, EFO_0004325 | |
| Disease | Hydrops Fetalis, Non-Immune | 1.44e-04 | 7 | 78 | 2 | C0455988 | |
| Disease | Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia | 1.44e-04 | 7 | 78 | 2 | C3714844 | |
| Disease | Pulmonary Hypertension, Primary, 1 | 1.44e-04 | 7 | 78 | 2 | C4552070 | |
| Disease | PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED | 1.44e-04 | 7 | 78 | 2 | C1969342 | |
| Disease | Pulmonary Hypertension, Primary, Fenfluramine-Associated | 1.44e-04 | 7 | 78 | 2 | C1969343 | |
| Disease | congestive heart failure (implicated_via_orthology) | 1.76e-04 | 41 | 78 | 3 | DOID:6000 (implicated_via_orthology) | |
| Disease | Streptozotocin Diabetes | 1.97e-04 | 108 | 78 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 1.97e-04 | 108 | 78 | 4 | C0011853 | |
| Disease | Alloxan Diabetes | 1.97e-04 | 108 | 78 | 4 | C0002152 | |
| Disease | Obesity | 2.16e-04 | 205 | 78 | 5 | C0028754 | |
| Disease | Cardiomyopathy, Dilated | 2.82e-04 | 48 | 78 | 3 | C0007193 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 3.18e-04 | 50 | 78 | 3 | C1449563 | |
| Disease | hypertension (biomarker_via_orthology) | 3.45e-04 | 227 | 78 | 5 | DOID:10763 (biomarker_via_orthology) | |
| Disease | mean arterial pressure | 3.56e-04 | 499 | 78 | 7 | EFO_0006340 | |
| Disease | eye measurement, sun exposure measurement | 3.74e-04 | 11 | 78 | 2 | EFO_0004731, EFO_0010729 | |
| Disease | Mental Depression | 5.75e-04 | 254 | 78 | 5 | C0011570 | |
| Disease | Idiopathic pulmonary arterial hypertension | 8.08e-04 | 16 | 78 | 2 | C3203102 | |
| Disease | Familial primary pulmonary hypertension | 9.14e-04 | 17 | 78 | 2 | C0340543 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 1.03e-03 | 18 | 78 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | response to selective serotonin reuptake inhibitor | 1.35e-03 | 82 | 78 | 3 | EFO_0005658 | |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 1.40e-03 | 21 | 78 | 2 | DOID:11612 (biomarker_via_orthology) | |
| Disease | Myocardial Reperfusion Injury | 1.50e-03 | 85 | 78 | 3 | C0027055 | |
| Disease | Lynch syndrome (is_implicated_in) | 1.83e-03 | 24 | 78 | 2 | DOID:3883 (is_implicated_in) | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 1.94e-03 | 93 | 78 | 3 | DOID:3525 (biomarker_via_orthology) | |
| Disease | chronic obstructive pulmonary disease | 2.29e-03 | 688 | 78 | 7 | EFO_0000341 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CVTASIETLCVIALD | 141 | P08588 | |
| CVTASIETLCVIAVD | 116 | P07550 | |
| CCTLSEEFACVDNLA | 461 | P43652 | |
| AELASCADLGTLCQA | 366 | Q86SQ4 | |
| DCCTSLVASDCLLVL | 2331 | Q7Z2Y8 | |
| LLAACSSESRELCFV | 281 | Q9Y6B7 | |
| CVALVLLAAAVSCAV | 6 | Q13510 | |
| VDVLCVTASIETLCA | 116 | P13945 | |
| ASCEFDCVDEVLTIA | 496 | Q7L7V1 | |
| VELATICALCNDSSL | 411 | O14983 | |
| VELATICALCNDSAL | 411 | Q93084 | |
| LAALDCAEETNSAVC | 96 | O00391 | |
| VSCCELAEEDFLAVS | 276 | Q96P11 | |
| SAALEDCALCQETLS | 781 | Q9HCC9 | |
| HDLTAICDASEACVS | 976 | P56524 | |
| ICDASEACVSALLGN | 981 | P56524 | |
| CACRSAAIDSCIAVT | 551 | Q4ZG55 | |
| EAAVLRAAVLACQAC | 376 | Q6PRD1 | |
| EENASDLCCLISSLV | 391 | Q9C0I1 | |
| ETDTCTACAGTLILE | 221 | Q9BZQ6 | |
| AAAGCQLVASCDIAV | 151 | Q96DC8 | |
| LTSDCCQDLASVLSA | 906 | Q9C000 | |
| SSAPALARECVVCAE | 591 | Q86XN8 | |
| IANLAATDVTFLLCC | 81 | Q969F8 | |
| LCCAAAAAAAAVASA | 21 | Q9H1U4 | |
| AEVSSSFVILCVCSL | 41 | Q8IWU2 | |
| ESVCVATASGDVILC | 81 | O95163 | |
| VDASNCLGISVLAEC | 141 | Q8IXQ5 | |
| CFITAAGCEDLASAL | 846 | Q96MN2 | |
| DDAEACFILSSRCEV | 376 | Q6UVM3 | |
| LASESEVIICLDCSS | 871 | Q9UKK3 | |
| EASRETCVALTDCLN | 406 | Q9BXW6 | |
| VSSFCSEALVTCAAL | 616 | Q8IZL8 | |
| QVLTSSCALDLDSAC | 546 | Q0VG06 | |
| LVTELSSCGFALDLC | 4281 | Q9UPN3 | |
| VELATICALCNDSAL | 411 | P16615 | |
| ATCVDLQLRTCSDAA | 41 | Q66K79 | |
| SACIDINECELSAHL | 1151 | P35555 | |
| AVSCVCTLLGALDEL | 426 | Q5TH69 | |
| CSCAEALLSGFEVID | 581 | O60503 | |
| AVLVAAVESLSCVQC | 11 | Q6UX82 | |
| EECDAVALLSLINSC | 131 | Q8TB03 | |
| ILSSGSDEECAICLD | 751 | Q14527 | |
| HDLTAICDASEACVS | 1006 | Q9UQL6 | |
| ICDASEACVSALLSV | 1011 | Q9UQL6 | |
| TAICDASEACVAALL | 846 | Q8WUI4 | |
| HDLTAICDASEACVN | 956 | Q9UKV0 | |
| PARLDSVDACVVAAC | 1476 | Q9BYK8 | |
| ALGSADLLVCNCAVA | 1306 | P49327 | |
| CCIAEVLITTRTAAD | 101 | P54277 | |
| CEEVCILSASGTAAV | 421 | Q86YS7 | |
| DDSDISLFVAAIICC | 371 | Q07869 | |
| VEATCACLLAQGEEA | 456 | Q9Y4I5 | |
| RDCSVCFESEVIAAL | 516 | Q6ZN04 | |
| SDNSAECVVCLSDVR | 271 | Q96PX1 | |
| VICCALSVTLAVDGA | 386 | Q7LBE3 | |
| GLLATSLDATCDVAC | 476 | Q8IXI1 | |
| ARCAALVATAEENLC | 716 | Q5UIP0 | |
| LDSLGLCSVSCALEF | 246 | Q9BSH4 | |
| CCVLTAALALQDTVS | 356 | P22732 | |
| SEATFSCDCVADALI | 91 | Q9H9Q4 | |
| DALCALDILSCAGFV | 136 | P49959 | |
| ISSEVCEDIASVLAC | 726 | Q7RTR0 | |
| EFAQVCSSDEDILCL | 926 | Q7KZ85 | |
| VSADTCSVCEAALLD | 766 | O95985 | |
| VDCFSALLSACETRD | 81 | Q6XCG6 | |
| DVIASERAAALCNAC | 151 | Q7Z392 | |
| VSACIGNCSTALEEL | 301 | Q5VWJ9 | |
| VAALDALSRECCVTA | 286 | O43818 | |
| LTSDNCALLCDAAAA | 101 | C9JR72 | |
| VVVIDECAQALEASC | 371 | P38935 | |
| ASLECLADTSDSCFL | 71 | Q96A56 | |
| SLEASLCSLEECAAF | 381 | Q9NS62 | |
| AACSAFATLEEEACT | 496 | O14787 | |
| RLLCVEFASVASCDA | 26 | O95551 | |
| AVVAVLESTLSCEAC | 366 | Q7Z7A4 | |
| SRVASCSCELLTDAV | 326 | O14492 | |
| EDVALAPCTAAAACE | 66 | P0DPA3 | |
| ILIVAHASSLEACTC | 571 | Q8TF42 | |
| ICDCLLATLANSESS | 1326 | Q69YN4 | |
| CRLTAAACDELASTL | 866 | P59046 | |
| DTINTSCDIELLAAC | 1096 | Q9UM54 |